DIADEMA PARTNERS LP
CIK 2026172 · View on SEC EDGAR ↗
- Portfolio value
- $791.3M
- Positions
- 149
- As of
- June 30, 2026
#2,851 of 9,443 by 13F value · top 30.2%
Portfolio value QoQ: +34.6% 13F does not disclose cash
- Top 10 holdings weight
- 37.34%
- Top 25 holdings weight
- 63.49%
- Positions above 1%
- 28
- Effective number of positions
- 44.5
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 32.57% Est. buys $452,824,841 · sells $224,600,848
Median holding: 2.0 quarters Tracked Q4 2024–Q2 2026 · 36.1% still held
- New positions
- 68
- Increased
- 35
- Decreased
- 24
- Closed
- 37
Put-notional exposure: 22.6% puts 13F reports option positions at underlying notional value — may include hedges, not necessarily bearish bets
On this page
- Performance vs S&P How this manager's 13F portfolio performed against the S&P 500.
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- High-conviction bets The holdings this manager is most concentrated in.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
Performance vs S&P 500
Annualized: +32.7% · S&P 500: +18.0%
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Priceable coverage: 95.3% · Options excluded: 62.9%
Sector breakdown
Healthcare
97.0%
Consumer Discretionary
0.0%
Other/Unmapped
3.0%
Full portfolio 149 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| VKTX Viking Therapeutics, Inc. - Common Stock | $47,623,408 | 6.02% | 1,220,800 | Call option | $26,173,040 | Up ×1 | |
| ABVX Abivax SA - American Depositary Shares | $46,534,392 | 5.88% | 349,200 | Call option | $35,399,392 | Up ×1 | |
| BMY Bristol-Myers Squibb Company Common Stock | $34,572,000 | 4.37% | 600,000 | Call option | |||
| ABVX Abivax SA - American Depositary Shares | $33,634,824 | 4.25% | 252,400 | Put option | $22,499,824 | Up ×1 | |
| UTHR United Therapeutics Corporation - Common Stock | $28,711,030 | 3.63% | 52,989 | $12,520,897 | Up ×2 | ||
| RVMD Revolution Medicines, Inc. - Common Stock | $26,072,747 | 3.29% | 139,218 | $18,207,945 | Up ×2 | ||
| ABVX Abivax SA - American Depositary Shares | $21,598,038 | 2.73% | 163,644 | $13,380,776 | Up ×3 | ||
| COGT Cogent Biosciences, Inc. - Common Stock | $19,104,797 | 2.41% | 493,664 | $6,681,611 | Up ×3 | ||
| BMY Bristol-Myers Squibb Company Common Stock | $19,049,172 | 2.41% | 330,600 | Put option | Up ×1 | ||
| Unknown issuer (CUSIP: 10806XAJ1) | $18,620,000 | 2.35% | 250,000 | $55,000 | |||
| CORT Corcept Therapeutics Incorporated - Common Stock | $17,937,785 | 2.27% | 206,300 | Call option | $11,548,650 | Up ×1 | |
| BMRN BioMarin Pharmaceutical Inc. - Common Stock | $17,901,048 | 2.26% | 312,846 | $9,527,592 | Up ×2 | ||
| VKTX Viking Therapeutics, Inc. - Common Stock | $17,234,930 | 2.18% | 441,808 | $145,540 | Down ×1 | ||
| KYMR Kymera Therapeutics, Inc. - Common Stock | $17,166,099 | 2.17% | 149,700 | Call option | Up ×1 | ||
| NVS Novartis AG Common Stock | $15,672,000 | 1.98% | 100,000 | Put option | Up ×1 | ||
| QURE uniQure N.V. - Ordinary Shares | $13,771,940 | 1.74% | 299,000 | Put option | $8,883,290 | ||
| VKTX Viking Therapeutics, Inc. - Common Stock | $13,673,005 | 1.73% | 350,500 | Put option | |||
| BIIB Biogen Inc. - Common Stock | $12,963,600 | 1.64% | 60,000 | Call option | Up ×1 | ||
| CAPR Capricor Therapeutics, Inc. - Common Stock | $12,868,352 | 1.63% | 534,400 | Put option | $-6,083,008 | Down ×1 | |
| SMMT Summit Therapeutics Inc. - Common Stock | $12,533,114 | 1.58% | 860,200 | Call option | |||
| LLY Eli Lilly and Company Common Stock | $11,994,300 | 1.52% | 10,000 | Put option | |||
| INCY Incyte Corporation - Common Stock | $11,948,144 | 1.51% | 105,400 | Put option | $2,027,896 | ||
| EWTX Edgewise Therapeutics, Inc. - Common Stock | $11,060,055 | 1.40% | 272,214 | ||||
| QURE uniQure N.V. - Ordinary Shares | $10,842,524 | 1.37% | 235,400 | Call option | $6,755,024 | Down ×1 | |
| BNTX BioNTech SE - American Depositary Shares | $9,305,000 | 1.18% | 100,000 | Call option | Up ×1 | ||
| KOD Kodiak Sciences Inc - Common Stock | $8,497,838 | 1.07% | 218,117 | $1,142,127 | Up ×1 | ||
| IMCR Immunocore Holdings plc - American Depositary Shares | $8,091,900 | 1.02% | 254,863 | $2,267,252 | Up ×2 | ||
| CAPR Capricor Therapeutics, Inc. - Common Stock | $7,929,544 | 1.00% | 329,300 | Call option | $-2,081,176 | ||
| NVS Novartis AG Common Stock | $7,836,000 | 0.99% | 50,000 | Call option | Up ×1 | ||
| REPL Replimune Group, Inc. - Common Stock | $7,708,041 | 0.97% | 696,300 | Call option | $6,135,966 | Up ×1 | |
| KOD Kodiak Sciences Inc - Common Stock | $7,663,432 | 0.97% | 196,700 | Call option | $7,655,808 | Up ×1 | |
| FDMT 4D Molecular Therapeutics, Inc. - Common Stock | $7,595,723 | 0.96% | 571,107 | Up ×1 | |||
| MRNA Moderna, Inc. - Common Stock | $7,003,000 | 0.88% | 100,000 | Put option | $-1,094,520 | Down ×1 | |
| HIMS Hims & Hers Health, Inc. Class A Common Stock | $6,934,000 | 0.88% | 200,000 | Call option | Up ×1 | ||
| RCUS Arcus Biosciences, Inc. Common Stock | $6,900,062 | 0.87% | 223,810 | $1,756,195 | Down ×1 | ||
| HIMS Hims & Hers Health, Inc. Class A Common Stock | $6,715,579 | 0.85% | 193,700 | Put option | Up ×1 | ||
| CRBP Corbus Pharmaceuticals Holdings, Inc. - Common Stock | $5,945,044 | 0.75% | 633,800 | Call option | $4,862,377 | Up ×1 | |
| SLS SELLAS Life Sciences Group, Inc. - Common Stock | $5,904,000 | 0.75% | 400,000 | Call option | $4,635,000 | Up ×1 | |
| KOD Kodiak Sciences Inc - Common Stock | $5,723,224 | 0.72% | 146,900 | Put option | $-3,688,604 | Down ×1 | |
| ALMS Alumis Inc. - Common Stock | $5,628,000 | 0.71% | 200,000 | Call option | $3,425,000 | Up ×1 | |
| RPRX Royalty Pharma plc - Class A Ordinary Shares | $5,607,000 | 0.71% | 100,000 | Call option | Up ×1 | ||
| JNJ Johnson & Johnson Common Stock | $5,587,340 | 0.71% | 22,000 | $-7,556,443 | Down ×2 | ||
| REPL Replimune Group, Inc. - Common Stock | $5,562,675 | 0.70% | 502,500 | Put option | $2,044,440 | Up ×1 | |
| BIOA BioAge Labs, Inc. - Common Stock | $4,904,451 | 0.62% | 200,100 | Call option | |||
| NVO Novo Nordisk A/S Common Stock | $4,809,442 | 0.61% | 100,000 | $4,288,706 | Up ×1 | ||
| BHVN Biohaven Ltd. Common Shares | $4,716,960 | 0.60% | 317,000 | Call option | $2,035,140 | ||
| TENX Tenax Therapeutics, Inc. - Common Stock | $4,466,850 | 0.56% | 307,000 | Call option | Up ×1 | ||
| CRVS Corvus Pharmaceuticals, Inc. - Common Stock | $4,404,476 | 0.56% | 294,811 | $822,891 | Up ×1 | ||
| RLAY Relay Therapeutics, Inc. - Common Stock | $4,315,967 | 0.55% | 230,677 | ||||
| TGTX TG Therapeutics, Inc. - Common Stock | $4,158,958 | 0.53% | 75,700 | Call option | Up ×1 | ||
| GLUE Monte Rosa Therapeutics, Inc. - Common Stock | $4,116,420 | 0.52% | 170,100 | Call option | Up ×1 | ||
| RCUS Arcus Biosciences, Inc. Common Stock | $3,822,920 | 0.48% | 124,000 | Call option | Up ×1 | ||
| UNCY Unicycive Therapeutics, Inc. - Common Stock | $3,717,294 | 0.47% | 792,600 | Call option | Up ×1 | ||
| ZYME Zymeworks Inc. - Common Stock | $3,715,330 | 0.47% | 142,132 | $156,345 | |||
| AMGN Amgen Inc. - Common Stock | $3,621,200 | 0.46% | 10,000 | Call option | |||
| BIOA BioAge Labs, Inc. - Common Stock | $3,586,646 | 0.45% | 146,334 | $2,537,246 | Up ×1 | ||
| TSHA Taysha Gene Therapies, Inc. - Common Stock | $3,559,035 | 0.45% | 522,619 | Up ×1 | |||
| NTLA Intellia Therapeutics, Inc. - Common Stock | $3,384,000 | 0.43% | 200,000 | Call option | $820,000 | ||
| CLDX Celldex Therapeutics, Inc. - Common Stock | $3,200,060 | 0.40% | 86,000 | Put option | Up ×1 | ||
| PCVX Vaxcyte, Inc. - Common Stock | $3,086,703 | 0.39% | 53,100 | Call option | $1,062 | ||
| NRIX Nurix Therapeutics, Inc. - Common stock | $2,948,536 | 0.37% | 121,539 | Up ×1 | |||
| SMMT Summit Therapeutics Inc. - Common Stock | $2,914,000 | 0.37% | 200,000 | Put option | |||
| PCVX Vaxcyte, Inc. - Common Stock | $2,842,557 | 0.36% | 48,900 | Put option | |||
| CRBP Corbus Pharmaceuticals Holdings, Inc. - Common Stock | $2,825,856 | 0.36% | 301,264 | $-1,305,340 | Down ×1 | ||
| INDV Indivior Pharmaceuticals, Inc. - Common Stock | $2,770,017 | 0.35% | 67,512 | $594,477 | Down ×1 | ||
| IVA Inventiva S.A. - American Depository Shares | $2,725,718 | 0.34% | 740,786 | $790,695 | Up ×2 | ||
| NVO Novo Nordisk A/S Common Stock | $2,679,846 | 0.34% | 55,900 | Put option | $625,521 | ||
| ORKA Oruka Therapeutics, Inc. - Common Stock | $2,645,631 | 0.33% | 27,799 | Up ×1 | |||
| PCVX Vaxcyte, Inc. - Common Stock | $2,619,977 | 0.33% | 45,071 | $1,163,101 | Up ×2 | ||
| CYTK Cytokinetics, Incorporated - Common Stock | $2,555,700 | 0.32% | 30,000 | Put option | $-10,626,300 | Down ×1 | |
| RLMD Relmada Therapeutics, Inc. - Common Stock | $2,500,660 | 0.32% | 361,367 | $1,102,800 | Up ×1 | ||
| VERA Vera Therapeutics, Inc. - Class A Common Stock | $2,471,959 | 0.31% | 57,608 | Up ×1 | |||
| VERA Vera Therapeutics, Inc. - Class A Common Stock | $2,145,500 | 0.27% | 50,000 | Put option | Up ×1 | ||
| CELC Celcuity Inc. - Common Stock | $2,092,400 | 0.26% | 20,000 | Call option | $72,122 | Up ×1 | |
| ANNX Annexon, Inc. - common stock | $2,016,772 | 0.25% | 353,200 | Call option | $60,044 | ||
| SEPN Septerna, Inc. - Common Stock | $1,999,353 | 0.25% | 59,700 | Put option | Up ×1 | ||
| CRVS Corvus Pharmaceuticals, Inc. - Common Stock | $1,992,996 | 0.25% | 133,400 | Call option | $437,827 | Up ×1 | |
| CTNM Contineum Therapeutics, Inc. - Common stock | $1,962,424 | 0.25% | 119,733 | Up ×1 | |||
| BCYC Bicycle Therapeutics plc - American Depositary Shares | $1,961,950 | 0.25% | 462,724 | $-248,657 | Down ×1 | ||
| GLUE Monte Rosa Therapeutics, Inc. - Common Stock | $1,897,062 | 0.24% | 78,391 | $-1,184,138 | Down ×1 | ||
| CLDX Celldex Therapeutics, Inc. - Common Stock | $1,893,989 | 0.24% | 50,900 | Call option | |||
| VRDN Viridian Therapeutics, Inc. - Common Stock | $1,837,000 | 0.23% | 100,000 | ||||
| MGNX MacroGenics, Inc. - Common Stock | $1,729,742 | 0.22% | 374,403 | $-4,258 | Down ×1 | ||
| PRQR ProQR Therapeutics N.V. - Ordinary Shares | $1,722,390 | 0.22% | 926,016 | $1,430,656 | Up ×3 | ||
| ADMA ADMA Biologics Inc - Common Stock | $1,674,000 | 0.21% | 200,000 | Call option | Up ×1 | ||
| SPRB Spruce Biosciences, Inc. - Common Stock | $1,620,000 | 0.20% | 30,000 | $966,500 | Up ×1 | ||
| ARDX Ardelyx, Inc. - Common Stock | $1,545,428 | 0.20% | 303,025 | ||||
| Unknown issuer (CUSIP: 22978P205) | $1,526,526 | 0.19% | 48,369 | Up ×1 | |||
| MLYS Mineralys Therapeutics, Inc. - Common Stock | $1,520,242 | 0.19% | 56,347 | $806,502 | Up ×2 | ||
| EYPT EyePoint, Inc. - Common Stock | $1,520,090 | 0.19% | 106,300 | Call option | $149,883 | ||
| SLS SELLAS Life Sciences Group, Inc. - Common Stock | $1,476,000 | 0.19% | 100,000 | Put option | Up ×1 | ||
| PRTA Prothena Corporation plc - Ordinary Shares | $1,463,429 | 0.18% | 149,482 | ||||
| VYGR Voyager Therapeutics, Inc. - Common Stock | $1,447,747 | 0.18% | 413,642 | $-187,511 | Down ×1 | ||
| UNCY Unicycive Therapeutics, Inc. - Common Stock | $1,424,240 | 0.18% | 303,676 | $726,214 | Up ×1 | ||
| PHAT Phathom Pharmaceuticals, Inc. - Common Stock | $1,409,958 | 0.18% | 129,950 | $802,796 | Up ×1 | ||
| EOLS Evolus, Inc. - Common Stock | $1,388,000 | 0.18% | 200,000 | Call option | $873,428 | Up ×2 | |
| SYRE Spyre Therapeutics, Inc. - Common Stock | $1,331,700 | 0.17% | 15,000 | Up ×1 | |||
| HELP Cybin Inc. - Common Stock | $1,322,000 | 0.17% | 200,000 | Up ×1 | |||
| CRMD CorMedix Inc. - Common Stock | $1,314,875 | 0.17% | 167,500 | Put option | $177,550 | ||
| EDIT Editas Medicine, Inc. - Common Stock | $1,296,000 | 0.16% | 400,000 | Call option | |||
| No matches | |||||||
Conviction holdings
Positions increased for 3+ consecutive quarters.
Share counts are as reported in 13F filings (not split-adjusted)
Biggest new bets
New positions opened this quarter, largest first.
| Security | Value | Shares | % of portfolio |
|---|---|---|---|
| BMY | $34,572,000 | 600,000 | 4.37% |
| BMY | $19,049,172 | 330,600 | 2.41% |
| KYMR | $17,166,099 | 149,700 | 2.17% |
| NVS | $15,672,000 | 100,000 | 1.98% |
| VKTX | $13,673,005 | 350,500 | 1.73% |
| BIIB | $12,963,600 | 60,000 | 1.64% |
| SMMT | $12,533,114 | 860,200 | 1.58% |
| LLY | $11,994,300 | 10,000 | 1.52% |
| EWTX | $11,060,055 | 272,214 | 1.40% |
| BNTX | $9,305,000 | 100,000 | 1.18% |
| NVS | $7,836,000 | 50,000 | 0.99% |
| FDMT | $7,595,723 | 571,107 | 0.96% |
| HIMS | $6,934,000 | 200,000 | 0.88% |
| HIMS | $6,715,579 | 193,700 | 0.85% |
| RPRX | $5,607,000 | 100,000 | 0.71% |
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| ABVX | Bought more | +249K | +$35.4M |
| VKTX | Bought more | +562K | +$26.2M |
| ABVX | Bought more | +152K | +$22.5M |
| RVMD | Bought more | +58K | +$18.2M |
| ABVX | Bought more | +88K | +$13.4M |
| UTHR | Bought more | +26K | +$12.5M |
| CORT | Bought more | +48K | +$11.5M |
| BMRN | Bought more | +165K | +$9.5M |
| QURE | Price move only | +0 | +$8.9M |
| JNJ | Trimmed | -32K | -$7.6M |
2 positions hidden (data completeness check)
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| VRTX | June 30, 2026 | 96,940 | $43,287,588 | 10.1% |
| AMGN | Sept. 30, 2025 | 114,200 | $31,885,782 | 54.5% |
| XBI | March 31, 2026 | 250,000 | $30,482,500 | No longer tracked |
| PRAX | March 31, 2026 | 100,600 | $29,650,844 | 14.7% |
| LQDA | June 30, 2026 | 712,100 | $26,874,654 | -12.2% |
| RNA | March 31, 2026 | 328,000 | $23,658,640 | -1.8% |
| VRTX | March 31, 2025 | 57,400 | $23,114,980 | 12.8% |
| APGE | June 30, 2026 | 222,500 | $18,727,825 | 1.6% |
| QQQ | March 31, 2026 | 30,000 | $18,429,300 | |
| XBI | March 31, 2025 | 200,000 | $18,012,000 | No longer tracked |
| ABBV | March 31, 2025 | 100,000 | $17,770,000 | 25.9% |
| BMY | Dec. 31, 2025 | 310,000 | $13,981,000 | 22.5% |
| SPY | Dec. 31, 2025 | 20,000 | $13,323,600 | No longer tracked |
| MRK | June 30, 2026 | 100,000 | $12,029,000 | 18.0% |
| REGN | March 31, 2026 | 15,300 | $11,809,611 | 8.4% |
| JAZZ | June 30, 2026 | 54,755 | $10,351,433 | 3.9% |
| GPCR | June 30, 2026 | 199,734 | $9,627,179 | -5.3% |
| TERN | June 30, 2026 | 181,752 | $9,581,965 | No longer tracked |
| ROIV | June 30, 2026 | 335,800 | $9,301,660 | 4.6% |
| INSM | March 31, 2026 | 52,800 | $9,189,312 | -23.3% |
| BMY | March 31, 2025 | 160,000 | $9,049,600 | 8.3% |
| ALNY | June 30, 2025 | 33,115 | $8,941,712 | -29.5% |
| AGIO | Dec. 31, 2025 | 222,100 | $8,915,094 | 24.1% |
| ACLX | March 31, 2025 | 110,100 | $8,443,569 | No longer tracked |
| IONS | March 31, 2026 | 106,200 | $8,401,482 | -20.3% |
| XBI | Sept. 30, 2025 | 100,000 | $8,293,000 | No longer tracked |
| INSM | March 31, 2025 | 106,337 | $7,341,506 | 64.4% |
| TEVA | March 31, 2025 | 300,000 | $6,676,648 | 141.8% |
| OCUL | March 31, 2026 | 545,200 | $6,618,728 | 33.1% |
| BBIO | June 30, 2026 | 85,311 | $6,335,195 | 11.0% |
| MRNA | Dec. 31, 2025 | 222,100 | $5,736,843 | 385.3% |
| BPMC | March 31, 2025 | 64,193 | $5,598,913 | No longer tracked |
| NBIX | Dec. 31, 2025 | 37,754 | $5,299,907 | 8.6% |
| ABBV | June 30, 2026 | 24,058 | $5,232,374 | 4.8% |
| CRSP | June 30, 2026 | 106,300 | $5,056,691 | 9.2% |
| SPRY | Sept. 30, 2025 | 280,700 | $4,898,215 | -44.5% |
| PFE | Sept. 30, 2025 | 200,000 | $4,848,000 | 10.1% |
| HALO | March 31, 2025 | 100,000 | $4,781,000 | 67.9% |
| VRTX | Sept. 30, 2025 | 10,000 | $4,452,000 | 39.6% |
| NKTR | Dec. 31, 2025 | 75,000 | $4,267,500 | 77.7% |
| ANIP | March 31, 2026 | 53,354 | $4,211,765 | 1.0% |
| ANAB | June 30, 2025 | 214,100 | $3,980,119 | 158.9% |
| AZN | March 31, 2025 | 30,000 | $3,931,781 | 125.2% |
| BHVN | March 31, 2025 | 100,000 | $3,735,000 | -40.7% |
| SRRK | Dec. 31, 2025 | 100,000 | $3,724,000 | 25.1% |
| SLNO | March 31, 2026 | 79,992 | $3,703,630 | No longer tracked |
| ARCT | Dec. 31, 2025 | 199,711 | $3,680,674 | 91.4% |
| ITCI | March 31, 2025 | 43,700 | $3,649,824 | No longer tracked |
| AQST | March 31, 2026 | 548,800 | $3,545,248 | 11.2% |
| GILD | Sept. 30, 2025 | 30,000 | $3,326,100 | 30.5% |
| TARS | March 31, 2025 | 60,000 | $3,322,200 | 40.7% |
| ARGX | Sept. 30, 2025 | 5,974 | $3,292,988 | 40.5% |
| APLS | March 31, 2025 | 100,000 | $3,191,000 | No longer tracked |
| RXRX | March 31, 2026 | 741,900 | $3,034,371 | 10.6% |
| CNTA | March 31, 2026 | 111,100 | $2,778,611 | No longer tracked |
| KALV | June 30, 2025 | 238,809 | $2,755,856 | No longer tracked |
| GOSS | March 31, 2026 | 877,100 | $2,719,010 | -53.3% |
| RYTM | June 30, 2025 | 50,000 | $2,648,500 | 73.7% |
| SWTX | June 30, 2025 | 60,000 | $2,647,800 | No longer tracked |
| ABUS | March 31, 2026 | 548,600 | $2,638,766 | 16.4% |
| SCPH | Dec. 31, 2025 | 462,000 | $2,619,540 | No longer tracked |
| CLDX | March 31, 2025 | 100,000 | $2,527,000 | 123.7% |
| RCUS | March 31, 2025 | 165,965 | $2,471,219 | 283.1% |
| CNTA | June 30, 2025 | 164,048 | $2,359,010 | No longer tracked |
| IRWD | March 31, 2026 | 683,611 | $2,303,769 | 21.1% |
| KROS | June 30, 2025 | 212,900 | $2,169,451 | -18.1% |
| ALKS | Dec. 31, 2025 | 72,079 | $2,162,370 | 71.8% |
| EWTX | June 30, 2025 | 98,200 | $2,160,400 | 234.8% |
| ALNY | March 31, 2026 | 5,341 | $2,123,849 | -30.6% |
| TECX | March 31, 2026 | 100,600 | $2,098,516 | 22.0% |
| ITOS | Sept. 30, 2025 | 206,200 | $2,055,814 | No longer tracked |
| PTGX | March 31, 2026 | 22,700 | $1,982,618 | 44.1% |
| CLYM | June 30, 2026 | 286,126 | $1,959,963 | 31.6% |
| TVTX | March 31, 2026 | 50,300 | $1,921,963 | 118.7% |
| ACAD | Dec. 31, 2025 | 89,000 | $1,899,260 | 8.8% |
| STTK | June 30, 2026 | 293,664 | $1,888,260 | 5.8% |
| TARS | June 30, 2026 | 25,942 | $1,819,831 | 14.8% |
| VTYX | March 31, 2026 | 200,000 | $1,806,000 | No longer tracked |
| ALT | March 31, 2026 | 491,800 | $1,775,398 | -2.3% |
| ALKS | June 30, 2026 | 50,000 | $1,768,000 | -8.3% |
| VNDA | March 31, 2026 | 200,000 | $1,764,000 | -22.7% |
| MBX | Dec. 31, 2025 | 100,000 | $1,750,000 | 110.3% |
| ORIC | March 31, 2025 | 214,291 | $1,729,328 | 151.5% |
| VRDN | Sept. 30, 2025 | 122,061 | $1,706,413 | 14.1% |
| MRK | Sept. 30, 2025 | 20,000 | $1,583,200 | 80.7% |
| SMMT | Dec. 31, 2025 | 74,700 | $1,543,302 | -25.1% |
| NVAX | Dec. 31, 2025 | 173,500 | $1,504,245 | 31.6% |
| LEGN | March 31, 2026 | 69,000 | $1,500,060 | 20.3% |
| BCRX | March 31, 2026 | 190,928 | $1,489,238 | 3.1% |
| CTMX | June 30, 2026 | 316,000 | $1,485,200 | -9.9% |
| ARDX | March 31, 2026 | 252,198 | $1,470,314 | -33.9% |
| AVXL | June 30, 2026 | 477,600 | $1,466,232 | 23.6% |
| ASND | March 31, 2026 | 6,840 | $1,458,562 | 12.7% |
| SAGE | June 30, 2025 | 183,466 | $1,458,555 | No longer tracked |
| BHVN | Sept. 30, 2025 | 100,000 | $1,411,000 | -5.0% |
| AMLX | Dec. 31, 2025 | 100,000 | $1,359,000 | 236.3% |
| KPTI | June 30, 2026 | 241,300 | $1,344,041 | -81.1% |
| CRNX | March 31, 2025 | 25,900 | $1,324,267 | 152.7% |
| ASND | June 30, 2025 | 8,321 | $1,296,911 | 49.4% |
| RIGL | March 31, 2026 | 30,000 | $1,284,900 | 68.8% |
| OLMA | June 30, 2026 | 84,000 | $1,252,440 | -10.6% |
| MNMD | Dec. 31, 2025 | 105,891 | $1,248,455 | No longer tracked |
| PCRX | March 31, 2026 | 48,025 | $1,242,887 | 6.2% |
| DNLI | March 31, 2025 | 60,000 | $1,222,800 | 85.1% |
| SKYE | Dec. 31, 2025 | 300,000 | $1,179,000 | -65.1% |
| NUVL | March 31, 2025 | 14,701 | $1,150,794 | No longer tracked |
| MPLT | March 31, 2026 | 63,791 | $1,120,489 | -44.9% |
| SUPN | Dec. 31, 2025 | 22,348 | $1,068,011 | -4.6% |
| IOVA | June 30, 2026 | 302,900 | $1,063,179 | 116.0% |
| FOLD | Dec. 31, 2025 | 131,400 | $1,035,432 | No longer tracked |
| TNGX | Sept. 30, 2025 | 200,000 | $1,024,000 | 186.1% |
| PRTA | March 31, 2026 | 106,539 | $1,017,447 | -5.5% |
| BNTX | March 31, 2025 | 8,767 | $999,000 | 25.9% |
| CPRX | Dec. 31, 2025 | 50,000 | $985,000 | No longer tracked |
| ETNB | Sept. 30, 2025 | 98,382 | $966,111 | No longer tracked |
| DSGN | March 31, 2026 | 100,320 | $941,002 | 44.1% |
| JANX | March 31, 2025 | 17,500 | $936,950 | -34.9% |
| BMEA | Sept. 30, 2025 | 493,900 | $889,020 | -32.2% |
| NMRA | March 31, 2025 | 81,200 | $860,720 | 55.5% |
| DNTH | June 30, 2026 | 10,000 | $839,200 | 14.7% |
| MREO | March 31, 2026 | 1,999,500 | $833,192 | -10.3% |
| ENTA | June 30, 2026 | 64,952 | $820,344 | -9.5% |
| IBRX | June 30, 2026 | 106,300 | $815,321 | -9.8% |
| CYTK | June 30, 2025 | 20,000 | $803,800 | 134.5% |
| VIR | June 30, 2026 | 88,800 | $795,648 | -7.7% |
| IOVA | March 31, 2025 | 100,000 | $740,000 | 169.8% |
| RARE | June 30, 2026 | 35,144 | $736,267 | -21.8% |
| VIR | March 31, 2025 | 100,000 | $734,000 | 45.2% |
| GHRS | March 31, 2025 | 101,502 | $710,514 | 162.2% |
| ARVN | Sept. 30, 2025 | 96,455 | $709,909 | 7.2% |
| GERN | March 31, 2025 | 200,000 | $708,000 | -2.2% |
| VRDN | March 31, 2026 | 21,114 | $657,068 | 25.9% |
| CRDF | Sept. 30, 2025 | 208,100 | $655,515 | -55.8% |
| EDIT | March 31, 2026 | 318,700 | $653,335 | 26.9% |
| MLTX | March 31, 2026 | 47,200 | $622,096 | -14.9% |
| PRTA | Sept. 30, 2025 | 100,000 | $607,000 | -5.8% |
| EOLS | June 30, 2025 | 50,000 | $601,500 | -9.9% |
| CTMX | Dec. 31, 2025 | 185,286 | $591,062 | -20.7% |
| UNBX | June 30, 2025 | 562,100 | $584,584 | No longer tracked |
| LGND | March 31, 2026 | 2,987 | $564,752 | 44.9% |
| STOK | March 31, 2026 | 17,181 | $545,325 | -2.4% |
| VERV | June 30, 2025 | 116,900 | $534,233 | No longer tracked |
| TNYA | Dec. 31, 2025 | 315,519 | $511,141 | -1.0% |
| AVTE | March 31, 2025 | 191,600 | $507,740 | No longer tracked |
| IMNM | March 31, 2026 | 22,500 | $483,300 | 31.3% |
| SAVA | June 30, 2025 | 309,900 | $464,850 | No longer tracked |
| BDTX | March 31, 2026 | 190,400 | $462,672 | 5.9% |
| MAZE | June 30, 2026 | 15,000 | $447,750 | -2.6% |
| JANX | June 30, 2026 | 31,600 | $439,240 | 14.5% |
| ONC | March 31, 2025 | 30,000 | $421,725 | 38.2% |
| ALEC | Dec. 31, 2025 | 136,023 | $402,628 | 45.8% |
| LPCN | June 30, 2026 | 50,000 | $399,500 | -18.4% |
| ALXO | March 31, 2025 | 236,580 | $395,089 | 225.8% |
| ERAS | March 31, 2025 | 156,973 | $394,002 | 1186.9% |
| PALI | March 31, 2026 | 166,049 | $390,215 | 19.7% |
| PHAT | Sept. 30, 2025 | 40,294 | $386,419 | -26.0% |
| NUVL | Sept. 30, 2025 | 5,000 | $381,500 | No longer tracked |
| CMPX | June 30, 2025 | 200,000 | $380,000 | -7.1% |
| GHRS | June 30, 2026 | 26,836 | $377,314 | 7.6% |
| ZVRA | March 31, 2025 | 42,081 | $350,956 | 58.5% |
| IMUX | June 30, 2025 | 317,800 | $346,402 | 2266.0% |
| PYXS | Dec. 31, 2025 | 150,000 | $333,000 | 174.3% |
| CCCC | Dec. 31, 2025 | 140,700 | $312,354 | 110.5% |
| WAVE | March 31, 2025 | 23,600 | $291,932 | 13.0% |
| EPRX | June 30, 2026 | 40,000 | $289,600 | 2.3% |
| CCCC | March 31, 2025 | 80,100 | $288,360 | 151.3% |
| CLYM | Dec. 31, 2025 | 136,488 | $274,341 | 329.0% |
| TRVI | June 30, 2026 | 21,663 | $258,440 | -1.8% |
| OVID | Dec. 31, 2025 | 187,739 | $244,061 | 71.8% |
| RLAY | Dec. 31, 2025 | 43,616 | $227,676 | 137.1% |
| AARD | March 31, 2026 | 15,882 | $208,451 | 61.3% |
| QTTB | March 31, 2025 | 60,400 | $207,776 | 880.0% |
| PBYI | March 31, 2026 | 33,800 | $201,110 | 44.5% |
| NEUP | March 31, 2026 | 50,000 | $194,000 | -2.9% |
| PLRX | March 31, 2026 | 144,914 | $176,795 | -11.1% |
| CMPS | June 30, 2026 | 31,885 | $176,324 | -2.4% |
| ELDN | Sept. 30, 2025 | 64,613 | $175,101 | 37.8% |
| ONC | March 31, 2026 | 7,500 | $172,784 | 26.6% |
| PASG | June 30, 2026 | 19,530 | $153,311 | -3.7% |
| SGMT | June 30, 2025 | 46,019 | $150,022 | 34.3% |
| CADL | June 30, 2025 | 25,045 | $141,504 | 151.3% |
| RVPH | March 31, 2026 | 500,000 | $139,500 | No longer tracked |
| ELEV | Sept. 30, 2025 | 362,935 | $133,233 | No longer tracked |
| RCEL | Dec. 31, 2025 | 25,100 | $128,261 | 193.9% |
| SABS | March 31, 2025 | 30,000 | $113,826 | 174.3% |
| RCKT | June 30, 2026 | 30,579 | $109,473 | 3.2% |
| INBX | March 31, 2026 | 1,299 | $102,621 | 49.5% |
| CMRX | March 31, 2025 | 29,082 | $101,205 | No longer tracked |
| ANAB | Dec. 31, 2025 | 3,295 | $100,893 | 18.5% |
| TVRD | Dec. 31, 2025 | 2,185 | $85,149 | -56.9% |
| LYEL | June 30, 2026 | 4,100 | $82,246 | 13.0% |
| LRMR | March 31, 2025 | 20,700 | $80,109 | 92.6% |
| EDSA | March 31, 2026 | 54,025 | $76,716 | -10.0% |
| KOD | March 31, 2025 | 7,300 | $72,635 | 1327.8% |
| ARVN | March 31, 2025 | 2,300 | $44,091 | 30.1% |
| SPRY | March 31, 2025 | 3,200 | $33,760 | -55.7% |
| MNMD | March 31, 2025 | 4,710 | $32,782 | No longer tracked |
| CUE | June 30, 2026 | 131,997 | $30,346 | -21.9% |
| SAVA | March 31, 2026 | 10,600 | $20,988 | No longer tracked |
| LVTX | March 31, 2025 | 21,508 | $20,454 | No longer tracked |
| APVO | March 31, 2025 | 4,050 | $17,456 | -87.8% |
| PMVP | Dec. 31, 2025 | 11,300 | $15,820 | 6.0% |
| ZLAB | Sept. 30, 2025 | 3,785 | $13,236 | -23.3% |
| PRTC | June 30, 2026 | 7,924 | $11,327 | No longer tracked |
| AUPH | Dec. 31, 2025 | 700 | $7,735 | 7.1% |
| APLT | March 31, 2026 | 20,200 | $2,020 | No longer tracked |
| LXRX | March 31, 2025 | 800 | $591 | 394.6% |